PMDA-2022-0083-V383

Type IB variation for application PMDA-2022-0083. Type IB variation: Labeling Change for Upadacitimab — minor update

Variation Number
PMDA-2022-0083-V383
Type
Type IB
Application
PMDA-2022-0083
Change
CHG-2022-0083
Status
Draft
Fee
€2,892
Submitted
—
Approved
—
Description

Type IB variation: Labeling Change for Upadacitimab — minor update